Sirolimus Lowers NMSC Risk in Transplant Recipients Renal and Urology News Acute rejection occurred in none of the sirolimus patients and in one of the CNI patients. The two groups had a similar incidence of treatment-emergent adverse events, but discontinuation rates were significantly higher in the sirolimus group (46.2% vs ... |
